4.7 Article

Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: A report by the shared equal access regional cancer hospital database study group

期刊

JOURNAL OF CLINICAL ONCOLOGY
卷 22, 期 3, 页码 446-453

出版社

AMER SOC CLINICAL ONCOLOGY
DOI: 10.1200/JCO.2004.04.181

关键词

-

类别

向作者/读者索取更多资源

Purpose Given the limited information regarding the impact of obesity on treatment outcomes for prostate cancer, we sought to examine the relationship between body mass index (BMI) and cancer control after radical prostatectomy (RP). Patients and Methods We compared clinicopathologic and biochemical outcome information across BMI groups from 1,106 men treated with BP between 1988 and 2002. Multivariate analysis was used to determine if BMI significantly predicted adverse pathology or biochemical recurrence. Results Obesity was related to year of surgery (P < .001) and race (P < .001), with black men having the highest obesity rates. Obese patients had higher biopsy and pathologic grade tumors (P < .001). On multivariate analysis, BMI greater than or equal to 35 kg/m(2) was associated with a trend for higher rates of positive surgical margins (P = .008). Overweight patients (BMI, 25 to 30 kg/m(2)) had a significantly decreased risk of seminal vesicle invasion (P = .039). After controlling for all preoperative clinical variables including year of surgery, BMI greater than or equal to 35 kg/m(2) significantly predicted biochemical failure after BP (P = .002). After controlling for surgical margin status, BMI greater than or equal to 35 kg/m(2) remained a significant predictor of biochemical failure (P = .012). There was a trend for BMI greater than or equal to 35 kg/m(2) to be associated with higher failure rates than BMI between 30 and 35 kg/m(2) (P = .053). Conclusion The percentage of obese men undergoing RP in our data set doubled in the last 10 years. Obesity was associated with higher-grade tumors, a trend toward increased risk of positive surgical margins, and higher biochemical failure rates among men treated with RP. A BMI greater than or equal to 35 kg/m(2) was associated with a higher risk of failure than a BMI between 30 and 35 kg/m(2). (C) 2004 by American Society of Clinical Cincology.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据